Cree, Inc. (CREE) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
Cree (CREE) Target Cut at Piper Jaffray
April 23, 2014 9:01 AM EDTPiper Jaffray analyst Mike Ritzenthaler lowered his price target on Neutral-rated Cree (NASDAQ: CREE) from $67 to $62 following O Q3 results but weak guidance.
Ritzenthaler comments, "We maintain our Neutral rating on CREE and lower our target to $62 (from $67) following F3Q14 results in... More
Cree (CREE) Numbers Cut at Northland Capital Markets Post Q3
April 23, 2014 8:24 AM EDTNorthland Capital Markets analyst Colin Rusch lowered his price target on Market Perform-rated Cree (NASDAQ: CREE) from $59 to $57 following Q3 results.
Rusch commented, "We remain on the sidelines with CREE shares as it appears operating leverage will be limited until... More
Goldman Sachs Comments on Cree's Q3 Miss (CREE)
April 23, 2014 7:42 AM EDTGoldman Sachs maintained a Buy rating on Cree (NASDAQ: CREE) with a price target of $66.00. Comments follow Q3 results. Analyst Brian Lee noted top line trends were intact, if not gaining, although margins missed.
"We were wrong to expect Cree to guide EPS well above consensus for June, and expect... More



